NDAORALTABLET
Approved
Apr 1995
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
2
Mechanism of Action
[formed from angiotensin I in a reaction catalyzed by angiotensin converting enzyme (ACE, kininase II)], is a potent vasoconstrictor, the primary vasoactive hormone of the renin-angiotensin system and an important component in the pathophysiology of hypertension. It also stimulates aldosterone…
Pharmacologic Class:
Thiazide Diuretic
Clinical Trials (2)
Hyzaar Asia HEAALTH (0954A-950)
Started Jun 2006
437 enrolled
Hypertension
Tarka vs. Hyzaar in Patients With Metabolic Syndrome (STAR)
Started Mar 2004
280 enrolled
HypertensionMetabolic Syndrome